 Denufosol tetrasodium INS37217 Intravitreal Injection may provide clinical benefit in treatment of uveitis associated macular edema UME by reducing retinal thickness as measured by OCT and possibly enabling recovery of vision loss associated with UME. Denufosol tetrasodium may also reverse the fluid accumulation of UME. 